The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...

Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting ...

China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina , just minutes ...

Health care giant Roche announced its plans recently for a new kind of sequencing analysis ... could lose more than $100 ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US tariffs on all Chinese goods, deepening the US company’s woes in one ...

Illumina (NASDAQ ... It also said it is instituting a $100 million cost reduction program for fiscal 2025. "Our new fiscal 2025 guidance provides for limited further earnings contribution from ...

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...